Rho d immune globulin 50 mcg
Products billed under this code include HyperRho S/D.
Payment limit per 50 MCG (250 IU), by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include HyperRho S/D.
Payment limit per 50 MCG (250 IU), by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| HyperRho S/D | Grifols USA, LLC | 13533-0661-06 | 10 | $276.53 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $27.653 | +$2.111 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted September 17, 2026 |
| 3Q26 | $25.542 | −$1.979 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted September 15, 2026 |
| 2Q26 | $27.521 | +$4.59 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted September 15, 2026 |
| 1Q26 | $22.931 | −$2.66 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted September 15, 2026 |
| 4Q25 | $25.591 | −$2.268 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted September 8, 2026 |
| 3Q25 | $27.859 | +$4.241 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted March 10, 2026 |
| 2Q25 | $23.618 | −$0.941 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted March 10, 2026 |
| 1Q25 | $24.559 | +$0.521 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted December 19, 2025 |
| 4Q24 | $24.038 | −$1.84 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted June 11, 2025 |
| 3Q24 | $25.878 | +$4.00 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted June 11, 2025 |
| 2Q24 | $21.878 | −$1.921 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted March 11, 2025 |
| 1Q24 | $23.799 | −$1.711 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted December 19, 2024 |
| 4Q23 | $25.51 | −$1.408 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted October 10, 2024 |
| 3Q23 | $26.918 | +$1.446 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted June 5, 2024 |
| 2Q23 | $25.472 | +$1.132 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted February 23, 2024 |
| 1Q23 | $24.34 | +$1.147 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted December 6, 2023 |
| 4Q22 | $23.193 | −$1.002 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted June 22, 2023 |
| 3Q22 | $24.195 | −$0.643 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted June 9, 2023 |
| 2Q22 | $24.838 | +$3.063 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted December 14, 2022 |
| 1Q22 | $21.775 | −$1.394 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted June 8, 2022 |
| 4Q21 | $23.169 | +$0.965 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted June 2, 2022 |
| 3Q21 | $22.204 | −$0.894 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted June 2, 2022 |
| 2Q21 | $23.098 | −$1.686 | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted March 1, 2022 |
| 1Q21 | $24.784 | – | 50 MCG (250 IU) | Rho d immune globulin 50 mcg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.